Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 103.66 +5.44 (5.54%)
Previous Close $98.22    52 Week High $118.49 
Open $99.79    52 Week Low $55.00 
Day High $103.71    P/E N/A 
Day Low $99.79    EPS $-0.56 
Volume 2,204,986       

(NASDAQ: MIRM) Delayed: 107.77 +0.64 (0.60%)
Previous Close $107.13    52 Week High $ 
Open $108.85    52 Week Low $ 
Day High $109.67    P/E N/A 
Day Low $106.69    EPS $ 
Volume 1,207,238